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Abstract
Objective: To investigate the extent to which GPs in the Netherlands participate in disease management and how personal opinions,
impeding and promoting incentives as well as physician characteristics influence their attitude towards disease management.
Methods: The attitude-model of Fishbein and Ajzen was used to describe the attitude of GPs towards disease management and main
influencing factors. After interviewing seventeen representatives of the GPs and testing a questionnaire, the final questionnaire was
sent to all GPs in the Netherlands (7680 GPs) barring those involved in the testing of the questionnaire.
Results: At least 10.4% of all Dutch GPs are active in disease management. The main factors predicting a positive attitude towards
disease management are the following: GPs’ opinion that they are improving quality and efficiency of care when executing disease
management, presence of a good quality network between actors involved prior to the start of disease management, working in a
health centre, and performing sideline activities besides their daily activities as GPs. The main factors predicting a negative attitude
are: GPs’ opinion that the investment-time is too high, lack of reimbursement for disease management activities, working in a solo
practice, and not performing any sideline activities beside their daily activities as GP.
Conclusions: The factors predicting a negative attitude of Dutch GPs towards disease management dominate the factors predicting a
positive attitude. The arguments in favour of disease management are matters of belief, for example concerning improvements in the
quality of care, while arguments against are more concrete barriers e.g. high workload and financial reimbursement. Placed on the
innovation timeline, the 10.4% participation might be taken to represent the start of a trend.
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Introduction
The concept of disease management has attracted
considerable interest in industrialised countries w1, 2x.
The reasons for this are the growing number of
chronically ill people, the limited capacity of health
care resources as well as the focus on treating
patients with a chronic disease in groups rather than
separately w3x. However, to achieve the objective of
treating personal care within a group-focused pro-
gramme is of the greatest importance. Disease man-
agement programmes claim to deliver efficient and
high quality health care services at affordable cost
w4, 5x. The definition of disease management used in
this study is the process of continuous improvement
in the measurable outcomes of the care continuum
(e.g. from prevention to reintegration) of a specific
disease w6x. The building bricks for this concept are
integrated and standardised care, focus on the whole
continuum of care of high-cost chronic diseases,
greater attention to prevention, screening and patientInternational Journal of Integrated Care – Vol. 2, 1 March, 2002 – ISSN 1568-4156 – http://www.ijic.org/
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empowerment, and comprehensive monitoring and
benchmarking of process and outcome results w4, 6x.
In the Netherlands, general practitioners (GPs) pro-
vide care for the majority of the chronically ill patients
w7x. Moreover, as primary caregivers, GPs are often
involved in the care for these patients for long periods
of time. Being the gatekeeper of the Dutch health care
system, the coordination of (primary) care for the
increasing group of chronically ill is regarded as a
GP’s task w7, 8x. Thus, the implementation and exe-
cution of disease management programmes for chron-
ically ill in the Netherlands must, to a great extent,
depend on the engagement of GPs in these
programmes.
Disease management for chronic and mostly complex
patient categories aims to deliver integrated and co-
ordinated health care, while at the same time promot-
ing appropriate, individual care. Being one of the
parties involved in disease management, GPs are
required to pay attention to co-morbidity and to the
prevention of fragmentation of care delivery in a more
systematic way. Both phenomena are very common
in patients suffering from a chronic disease w9x. Due
to improved education, increased application of Infor-
mation Technology Communication, acceptance of a
change in care practices from physicians to nurses
and the use of national guidelines for clinical practice,
the working method of GPs seems to be better
equipped for the anticipatory working method acquired
to manage chronic diseases. Instead of ‘gatekeeper
of the health care system’, the role of the GP might
evolve towards ‘manager of the primary care process’
w9, 10x.
The purpose of this study is to describe and explain
the activity of GPs in the field of disease management.
The research questions addressed are: (a) How many
GPs are currently implementing disease management;
(b) What barriers and enabling factors do GPs per-
ceive in implementing disease management; (c) What
personal opinions influence the attitude of GPs to-
wards disease management; (d) Do physician char-
acteristics influence the attitude of GPs towards
disease management?
The attitude-model of Fishbein and Ajzen was used
to describe the attitude of GPs towards disease man-
agement and the main factors influencing this attitude
w11x. Fishbein and Ajzen assume that human beings
are basically rational information processors whose
beliefs, attitudes, intentions and behaviours are in-
fluenced by the information available to them w11x.
According to this theory the development of an attitude
takes place on the base of information that is accepted
by the subject. This information leads to opinions,
which subsequently lead to an attitude. Changes in
opinion take place by evaluating and receiving feed-
back from an attitude-object w11, 12x. This model was
chosen because it can predict the intentions of GPs
to participate in disease management on the base of
their personal attitudes towards disease management.
Methods
Both quantitative and qualitative research methods
were used in this study. In order to construct a
questionnaire that would be valid in a national context,
open interviews were held with GP representatives.
Subsequently a questionnaire consisting of 32 closed
questions was tested and refined in a pilot setting.
The pilot consisted of sending the questionnaire to
315 GPs in one province of the Netherlands to meas-
ure participation in disease management as well as
the GPs’ motives for doing so. The final questionnaire
(28 closed questions) was sent to all GPs in the
Netherlands except those in the province in which the
questionnaire was tested (7680 GPs). A front page
was added to both questionnaires which contained
questions as to whether the respondent was active in
disease management or not, and whether the respon-
dent was prepared to answer further questions on
disease management.
In order to determine the number of GPs that clearly
carry out disease management activities, a formula
was constructed to measure whether a disease man-
agement programme could be regarded as clear dis-
ease management. The method we used to assess
disease management is described in Appendix 1. In
one district all the ‘disease management’ programmes
(ns42) were independently assessed by three per-
sons on the basis of the formula.
Results
Participation of GPs in disease manage-
ment in the Netherlands
The response rate for the pilot questionnaire was
48.9% (ns154), while that for the national question-
naire was 41.3% (ns3170). Since the items used to
answer the research question were part of both pilot
version and final version of the questionnaire, the
responses to these items from both versions were
used. The total response rate was 41.6% (ns3324),
with completed questionnaires from 1673 respon-
dents. Eight-hundred and thirty-four of all the respon-
dents played an active role in disease management.
This amounts to 10.4% of the total of 7995 DutchInternational Journal of Integrated Care – Vol. 2, 1 March, 2002 – ISSN 1568-4156 – http://www.ijic.org/
3 This article is published in a peer reviewed section of the International Journal of Integrated Care
Table 1. Arguments in favour of and against participation in disease management programmes
Arguments in favour of disease management Arguments against disease management
(ns1673)( ns1673)
Improving the quality of care (90.2%) The high time-investment required (72.1%)
Improving the efficiency of care (64.5%) Lack of (financial) reimbursement for
participation in disease management
programmes (45.5%)
Improving the quality of life of patients (64.0%) No expectation that disease management will
save time in the long term (30.8%)
Table 2. Promoting and impeding incentives for disease management
Promoting incentives (ns1673) Impeding incentives (ns1673)
The presence of a network between the The high time-investment required (71.8%)
different actors, prior to the start of disease
management (60.8%)
Qualitative good cooperation between The extent to which disease management
actors (60.0%) activities are reimbursed (34.5%)
Positive perspective that disease The expectation that disease management
management programs will be continued programmes will not lead to any time-saving
(42.7%) (23.8%)
GPs. The participation in disease management varied
between 7.3% and 15.3% over the 23 GP-districts.
Of the assessed projects, 45.2% scored above the
breakpoint for disease management (5.4) and can be
regarded as a disease management project; 54.8% of
the projects scored lower than the breakpoint. Of the
disease management programmes described, 88.1%
focused on diabetes mellitus, followed by asthmay
chronic obstructive pulmonary disease (19.4%) and
deep-vein-thrombosis (15.5%).
Arguments in favour of and against dis-
ease management (personal opinions)
The most frequently mentioned arguments by GPs
(not) to participate in disease management are in
Table 1.
Promoting and impeding incentives for
disease management
The most frequently mentioned promoting and imped-
ing incentives for disease management are in Table
2.
Physician characteristics that influence
participation in disease management
Of the 189 GPs who are working in a health centre
79.4% are active in disease management, against
49.0% of the 298 GPs working in a group practice
and 43.0% of the 617 GPs working in a solo-practice.
Of the remaining 569 GPs, 495 are working in other
kind of practices such as duo practices, while for
74 GPs there are no data available.
GPs who perform sideline activities, such as phar-
maco-therapeutic consultation sessions, or who per-
form medical coordination tasks beside their daily
activities, participate more often in disease manage-
ment programmes than GPs who are not involved in
such activities. Of the 820 GPs who perform sideline
activities, 8.2% also participate in disease manage-
ment programmes, against 16.3% of the GPs who do
not perform any sideline activities. For 14 GPs there
are no data on performing sideline activities available.
There seems to be no relation between GP age and
participation in disease management programmes.
Gender also does not appear to affect participation.
Discussion
Since disease management is attracting more and
more interest in the Netherlands, GPs are considered
one of the most important actors in implementing and
executing disease management programmes w6, 8,
13–15x. The purpose of this study is to investigate to
what extent GPs in the Netherlands are participating
in disease management programmes, and how per-
sonal opinions, impeding and promoting incentivesInternational Journal of Integrated Care – Vol. 2, 1 March, 2002 – ISSN 1568-4156 – http://www.ijic.org/
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and physician characteristics influence attitudes. As a
first step a formula was defined to assess disease
management programmes.
At least 10.4% of the Dutch GPs are active in the field
of disease management according to their own defi-
nition of this concept. Since the GPs who did not
return the questionnaire are not included but might be
active in disease management, the percentage of
10.4% represents the minimum number of the 7995
Dutch GPs that are active in disease management.
The reason for not including the non-respondents lay
in our suspicion that GPs who are active in disease
management were more likely to return the question-
naire than GPs who are not. Generalisation would
then lead to an overestimation of the number of GPs
that are active in the field of disease management.
When the derived formula was applied, it became
evident that 54.8% of the programmes mentioned by
GPs do not meet all of the minimal prerequisites of
this concept, although most of these programmes do
have the potential to become clear disease manage-
ment projects. The number shows that GPs overesti-
mate their engagement in disease management.
The argument most often mentioned by the respon-
dents against disease management is the high time
investment required. A possible explanation is the
high work pressure that GPs experience w16, 17x.
Setting limits to this time investment should lead to
more active participation of GPs in disease manage-
ment programmes. There are several ways of reduc-
ing the time invested. One is to shift certain tasks to
nursing practitioners w13x, another lies in the increased
use of information technology by GPs so that the
registration and transaction of data do not require
extra time w18x. In addition, the idea that disease
management takes more time than delivering tradition-
al care has to be changed. GPs should be convinced
of the fact that disease management implies a change
in daily activities rather than an increase in activities
in the long term w5x. For the investment time that is
left GPs should then receive an appropriate reward.
GPs did not mention the extent of information com-
munication technology as a factor impeding disease
management while the practice shows that this is
currently one of the most impeding factors.
Improving the quality of care, efficiency of care and
quality of life were mentioned as the most important
arguments for GPs to participate in disease manage-
ment programmes. This is confirmed by the high
weight factor that GPs assign to the main element
‘Continuous improvement in the efficiency and quality
of the primary care process’. The fact that GPs men-
tion the amount of time invested as an impeding
incentive can be explained by the high work pressure
they experience w19x. The second factor, ‘lack of
reimbursement’, might also be related to this. GPs
feel that they have to perform even more ‘extra’ tasks
while not receiving reimbursements of any kind w17,
20x. An example of such tasks is the shift in care from
the secondary to the primary care sector and
enhanced data registration. If GPs fail to receive any
compensation for these extra activities they are less
willing to cooperate.
Networks of good quality between the different parties
prior to the start of a disease management programme
are regarded as a promoting incentive for disease
management. Stimulating the formation and mainte-
nance of these networks, for example in a health care
centre, could lead to greater GP participation in dis-
ease management programmes. One advantage of
closer cooperation in general is that GPs are more
willing to participate when they feel that the network
of which they are part is of high quality and that they
can trust the other parties involved. The literature on
disease management shows that trust is an important
factor in the successful implementation of disease
management, since participation in a network means
the sharing of knowledge, data and autonomy w12,
21x. The present study also shows that GPs who are
working in a health care centre are more active in
disease management than GPs who run group or solo
practices.
The positive prospect that disease management pro-
grammes will be continued is another factor in favour
of disease management. A more structural form of
financing the programmes as well as an unequivocal
policy with regard to managing the chronically ill now
and in the future would further improve the prospect
for continuity w4, 12x.
The attitude-model of Fishbein and Ajzen gives a clear
insight into how the attitude of GPs towards disease
management is influenced by personal opinions—
arguments in favour for or against disease manage-
ment—and the promoting and impeding factors that
promote or impede disease management. On the base
of this model one might assume that the impeding
factors and the arguments against disease manage-
ment are of greater influence on the attitude of GPs
than the promoting factors and the arguments in
favour of disease management. It is noticeable that
the arguments in favour of disease management are
matters of belief—for example improving the quality
of care—and that the arguments against are more
concrete and concern high workload, financial reim-
bursement and time-investment. This shows that the
practical barriers in the health care system are alsoInternational Journal of Integrated Care – Vol. 2, 1 March, 2002 – ISSN 1568-4156 – http://www.ijic.org/
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of great influence in the GPs’ decisions to participate
in disease management programmes.
However, since the number of GPs that are active in
disease management is relatively small, it does not
mean that disease management has no chance of
succeeding in the Netherlands. If this cross-sectional
survey is placed on the innovation timeline, the 10.4%
participation might be taken to represent the start of
a trend w22x. Furthermore, the discussions about dif-
ferent aspects of disease management—such as
increased transparency, efficiency of care and shared
responsibilities—have become less loaded in the last
five years. The implementation process of disease
management has not yet been completed and the
concept is slowly being integrated into the Dutch
health care system. Cooperation and integrated care
are key words for the future w23x.
Health Technology Assessment of disease manage-
ment, with the purpose of investigating what impact
disease management in The Netherlands will have on
health care and economic outcomes, is strongly rec-
ommended. Further research on the formula for dis-
ease management and correcting this formula for the
influence of other parties (e.g. insurers, specialists)
on the weight factors is recommended. Since the
subdivisions of the formula and the scores represent-
ing them are arbitrary, further research into this subject
should be conducted.
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Appendix 1: The assessment of
disease management
Open interviews were performed with members of 17
of the 23 District General Practitioners Associations
(in Dutch: Districts Huisartsen Verenigingen (DHV)).
During the interviews, it was noticed that representa-
tives did not know exactly what disease management
implies. They mentioned some characteristics of dis-
ease management but could not give an overall defi-
nition. As a result two possible errors might occur:
1. GPs assume they are carrying out disease man-
agement activities but, according to the definition,
are not in fact;
2. GPs assume they are not performing any disease
management activities but, according to the defi-
nition, they are.
Based on the information obtained from the open
interviews, four main elements of disease manage-
ment were defined: ‘multidisciplinary working meth-
ods’, ‘working with clinical guidelines’, ‘designing and
adjusting the primary care process based on patient
outcomes’ and ‘continuous improvement in the effi-
ciency and quality of the primary care process’. These
main elements correspond to the elements of disease
management as mentioned in the definition by the
STG w6x that was used in this study. In addition, the
main elements of disease management show a lot of
similarities with continuous quality improvement. The
combination of these principles and programmes of
continuous quality improvement provides great oppor-
tunities for delivering and continuously improving a
best practice approach to health care delivery w24x.
When the programmes described in the open inter-
views were assessed it appeared that the practical
applications of the main elements differed strongly. In
order to assess the programmes more accurately
subdivisions were made for every main element.
These subdivisions vary from minimal application of
the main element to maximal application. Within each
element one of the subdivisions formulated was deter-
mined as being the minimal prerequisite for this main
element of disease management. Each subdivision
was scored between 0 and 3 (0sminimal application
of the main element; 3smaximal application of the
main element). With these scores it was possible to
give a more detailed opinion whether the project could
be regarded as a clear disease management project
or not. Table 3 shows the main elements and minimal
prerequisites for disease management. Weight factors
are used to express the ratio between the four main
elements of disease management (Figure 1). The
weight factors were derived by asking the GPs to rate
the four main elements of disease management on a
five-point scale (1snot important at all; 5svery impor-
tant). The weight factors as represented in this study
are the mean values GPs assigned to the main
elements.
Because of the comprehensive nature of the elements
B and C, they were both divided into two subcatego-
ries (B , B , C and C ) each with the same weight 121 2
factor as the main element from which they are
extracted.
Thus, on the one hand the formula is based on the
weight factors GPs assigned to the main elements of
disease management, and on the other hand on theInternational Journal of Integrated Care – Vol. 2, 1 March, 2002 – ISSN 1568-4156 – http://www.ijic.org/
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Table 3. Main elements and minimal prerequisites for disease management
A. Multidisciplinary working method
0scooperation within general practice
1scooperation with at least one other general discipline (primary care)
2scooperation with at least one other specialized discipline (secondary care)
3scooperation with at least two other disciplines of which one should be a general and one should be a specialised discipline
B. Working with clinical guidelines
• B1: The extent to which the continuum of care is described in the clinical guidelines
0sno clinical guidelines are used
1sthe clinical guidelines describe diagnostics, treatment and care
2sthe clinical guidelines also describe prevention, rehabilitation or reintegration
3sthe clinical guidelines describe at least two of the elements: prevention, rehabilitation and reintegration
• B2: The extent to which the population-based approach and the focus on one specific disease are embedded in the clinical
guidelines
0sthe population-based approach and the focus on one specific disease are not embedded in the clinical guidelines
1sthe population-based approach is not embedded in the clinical guidelines, the focus on one specific disease is embedded.
2sthe population based approach and the focus on one specific disease are embedded in the clinical guidelines
3sthe population based approach and the focus on one specific disease including co-morbidity are embedded in the clinical
guidelines
C. Designing and adjusting the primary care process based on patient outcomes
• C1: The extent to which the design of the primary process is based on systematically registered patient outcomes
0sno patient outcomes are used to design the primary care process and no patient outcomes are systematically registered
1sthe design of the process is based on systematically registered patient outcomes
2spatient outcomes are registered systematically during the project
3spatient outcomes are registered systematically at the population level
• C2: The extent to which adjusting of the primary care process and benchmarking of patient outcomes takes place
0sno adjustment of the primary care process and no benchmarking take place
1spatient outcomes are benchmarked to the care givers
2sthe primary care process is adjusted, based on patient outcomes
3spatient outcomes are benchmarked and the primary care process is adjusted, based on patient outcomes
D. Continuous improvement in the efficiency and quality of the primary care process
0scontinuous improvement in the efficiency and quality of the primary care process is not a goal of registration and benchmarking
of patient outcomes
1sclinical andyor psychosocial outcomes (quality improvement), or economic outcomes (efficiency improvement), or process out-
comes process outcomes) are registered to adjust the primary care process
2soutcomes of two of the three mentioned categories (clinicalypsycho-social, economic, process) are registered to adjust the pri-
mary care process
3sthe outcomes of all three categories (clinicalypsychosocial, economic, process) are used to adjust the primary care process
scores they assigned to the subdivisions that repre-
sent the main elements.
1 YsmeanA=scoreAq / (meanB =scoreB 21 1
qmeanB =scoreB )q(meanC =scoreC 22 11
qmean C =scoreC )qmeanD=scoreD 22
Completing the formula with the mean weight factors
and the scores that represent the minimal prerequi-
sites for each element leads to the breakpoint for what
can be regarded as disease management. The break
point is necessary to determine whether a project can
be seen as a clear disease management project or
not, and is convertible to a ten-point scale (0sno
disease management at all; 10soptimal disease
management).
Completing the formula with the scores that represent
the minimal prerequisites results in
1 Ys3.8=2q / (3.7=2q3.7=2) 2
1 q / (3.9=2q3.9=1)q3.9=1s24.75. 2
Completing the formula with the maximum scores
results in
1 Ys3.8=3q / (3.7=3q3.7=3) 2
1 q / (3.9=3q3.9=3)q3.9=3s45.9. 2
If 45.9s10, then 24.75s5.4. This is taken to be the
breakpoint for disease management.International Journal of Integrated Care – Vol. 2, 1 March, 2002 – ISSN 1568-4156 – http://www.ijic.org/
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Figure 1. Weight factors for the disease management formula.
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